BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 1, 2017
View Archived Issues
ATYR-1940 granted U.S. orphan drug designation for the treatment of limb girdle muscular dystrophy
Read More
FDA grants orphan drug designation to ustekinumab for the treatment of pediatric ulcerative colitis
Read More
EMA committee hands down positive opinion for 8-week regimen of Viekirax + Exviera
Read More
FDA requests additional information to complete IND review for Titan's ropinirole implant
Read More
FDA awards fast track designation to Immunopulse IL-12 for metastatic melanoma
Read More
WHO publishes list of antibiotic-resistant priority pathogens
Read More
Sanofi seeks Japanese approval for dupilumab for atopic dermatitis
Read More
FDA grants rare pediatric disease designation to SB-318 for MPS I
Read More
Phase III pediatric study of Latuda for bipolar I depression meets primary endpoint
Read More
Immune Pharmaceuticals broadens enrollment criteria in bullous pemphigoid study of bertilimumab
Read More
Accera announces results from phase III study of AC-1204 for mild to moderate Alzheimer's disease
Read More
Bremelanotide improves desire and distress in hypoactive sexual desire disorder
Read More
miR-223 found to play a role in alcoholic liver disease
Read More
Astellas and Affinivax enter worldwide partnership for MAPS vaccine targeting pneumococcus
Read More
Vycellix and Moffitt Cancer Center establish collaborative research agreement
Read More
TGFB2 has a pathogenic role in Alzheimer's disease and dementia with Lewy bodies
Read More
Cancer Research UK and HitGen announce license agreement in lung cancer
Read More
Kevzara becomes available in Canada
Read More
Immunologic responses seen with vesigenurtucel-L in non-muscle invasive bladder cancer
Read More
FDA grants priority review to avelumab BLA for metastatic urothelial carcinoma
Read More
Johnson & Johnson completes acquisition of Abbott Medical Optics
Read More
Perrigo signs agreement to divest Tysabri royalty stream
Read More
FDA approves Xermelo for carcinoid syndrome diarrhea
Read More
ZUMA-1 study of axicabtagene ciloleucel meets primary endpoint of objective response rate
Read More
FDA accepts Dynavax's response to Heplisav-B complete response letter
Read More
